home ver. 2.3. site index contact us

Message from the CEO
How We Work
History of Schering-Plough
Management Team
Schering-Plough Worldwide
Speeches & Presentations
The Schering-Plough Foundation
Diversity & Inclusion
Workforce Diversity
Supplier Diversity
Supplier Registration

Diversity: A Way of Life at
Schering-Plough

As a global company with a Vision based on earning the trust of stakeholders around the world, we're immersed in diversity every day.

We experience diversity in a variety of ways:

• There is great diversity in race/ethnicity, gender, age,   orientation, and ability among our people, who also bring a  broad range of ideas, interests and experiences to their work.

• We lend our diverse talents to cross-functional teams, working   across the conference room table as well as across the globe.

• Through our business partnerships and alliances, we   experience differences in each company's culture and   leadership.

Spotlight On

Combination Brochure

Brochure on the Combination

Basic Facts and Figures
•  World Headquarters:
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530
•  Chairman and CEO:
Fred Hassan
Number of employees:
55,000
Net sales (2007):
$12.7 billion
Business operations in more than:
140 countries
Largest-selling products:
VYTORIN*, ZETIA*, REMICADE, NASONEX.
R&D investment (2007):
$2.9 billion
Areas of research:
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $5.2 billion in 2007.
 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough